Targeting NF-κB in hematologic malignancies

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Cell Death and Differentiation

• Publication date

  2006-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.cdd.4401874
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of IAP family proteins in myelodysplastic syndromes transforming to overt leukemia

  2007cited by this paper
• From bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 28, 2013. For personal use only.

  2007cited by this paper
• The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status.

  2006cited by this paper
• Curcumin suppresses constitutive activation of AP-1 by downregulation of JunD protein in HTLV-1-infected T-cell lines.

  2006cited by this paper
• A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

  2005cited by this paper
• Constitutive NF-kappaB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity.

  2005influential reference
• Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphoma.

  2005cited by this paper
• NF-κB constitutes a potential therapeutic target in high-risk myelodysplastic syndrome

  2005cited by this paper
• Chemosensitization by erythropoietin through inhibition of the NF-κB rescue pathway

  2005influential reference
• Rapamycin stimulates apoptosis of childhood acute lymphoblastic leukemia cells.

  2005cited by this paper
• Autocrine VEGF mediates the antiapoptotic effect of CD154 on CLL cells

  2005influential reference
• Role for the nuclear factor kappaB pathway in transforming growth factor-beta1 production in idiopathic myelofibrosis: possible relationship with FK506 binding protein 51 overexpression.

  2005cited by this paper
• AT514, a cyclic depsipeptide from Serratia marcescens, induces apoptosis of B-chronic lymphocytic leukemia cells: interference with the Akt/NF-κB survival pathway

  2005cited by this paper
• NF-kappaB and FLIP in arsenic trioxide (ATO)-induced apoptosis in myelodysplastic syndromes (MDSs).

  2005cited by this paper
• Phase 1 trial of the proteasome inhibitor bortezomib and pegylated liposomal doxorubicin in patients with advanced hematologic malignancies.

  2005cited by this paper
• B cells.

  2005cited by this paper
• Reactive oxygen signaling and MAPK activation distinguish Epstein-Barr Virus (EBV)-positive versus EBV-negative Burkitt's lymphoma.

  2005cited by this paper
• Bortezomib or high-dose dexamethasone for relapsed multiple myeloma.

  2005cited by this paper
• Targeting NF-κB activation via pharmacologic inhibition of IKK2-induced apoptosis of human acute myeloid leukemia cells

  2005cited by this paper
• Proteasome inhibition as a novel therapeutic target in human cancer.

  2005cited by this paper
• Elevated NF-κB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas

  2005cited by this paper
• Properties of thalidomide and its analogues: Implications for anticancer therapy

  2005cited by this paper
• A unique clonal JAK 2 mutation leading to constitutive signalling causes polycythaemia

  2005cited by this paper
• Targeting NF-kappaB activation via pharmacologic inhibition of IKK2-induced apoptosis of human acute myeloid leukemia cells.

  2005influential reference
• NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes.

  2005cited by this paper
• Myeloproliferative disorders: the centrosome connection

  2005cited by this paper
• Transcriptional activation of survivin through the NF‐κB pathway by human T‐cell leukemia virus type I tax

  2005cited by this paper
• Expression of the NF‐κB targets BCL2 and BIRC5/Survivin characterizes small B‐cell and aggressive B‐cell lymphomas, respectively

  2005cited by this paper
• Apoptotic resistance to ionizing radiation in pediatric B-precursor acute lymphoblastic leukemia frequently involves increased NF-kappaB survival pathway signaling.

  2004cited by this paper
• Expression of IAP family proteins in myelodysplastic syndromes transforming to overt leukemia.

  2004cited by this paper
• A sustained activation of PI3K/NF-κB pathway is critical for the survival of chronic lymphocytic leukemia B cells

  2004cited by this paper
• Part I: Hodgkin's lymphoma--molecular biology of Hodgkin and Reed-Sternberg cells.

  2004cited by this paper
• The c-Rel transcription factor and B-cell proliferation: a deal with the devil

  2004cited by this paper
• Constitutive NF-kappab/Rel activation in philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL).

  2004cited by this paper
• Bcl10 activates the NF-κB pathway through ubiquitination of NEMO

  2004cited by this paper
• Nuclear factor-kappaB: the enemy within.

  2004influential reference
• Transcriptional activation of hTERT through the NF-kappaB pathway in HTLV-I-transformed cells.

  2004cited by this paper
• NF-kappaB/Rel-mediated regulation of apoptosis in hematologic malignancies and normal hematopoietic progenitors.

  2004influential reference
• Constitutive NF-κB/Rel Activation in Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)

  2004cited by this paper
• Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO.

  2004influential reference
• Signaling to NF-kappaB.

  2004influential reference
• c-FLIP Mediates Resistance of Hodgkin/Reed-Sternberg Cells to Death Receptor–induced Apoptosis

  2004cited by this paper
• Nuclear factor-κB: The enemy within

  2004cited by this paper
• MALT lymphoma: from morphology to molecules

  2004cited by this paper
• The IKK NF-kappa B system: a treasure trove for drug development.

  2004cited by this paper
• Expression of constitutively active nuclear-kappa B RelA transcription factor in blasts of acute myeloid leukemia.

  2004cited by this paper
• Mechanisms of Bcr-Abl-mediated NF-kappaB/Rel activation.

  2003cited by this paper
• Novel therapeutic approaches for multiple myeloma

  2003cited by this paper
• Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma.

  2003cited by this paper
• The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.

  2003cited by this paper
• Effect of NF-kappaB/Rel inhibition on spontaneous vs chemotherapy-induced apoptosis in AML and normal cord blood CD34+ cells.

  2003cited by this paper
• Expression of FLIPLong and FLIPShort in bone marrow mononuclear and CD34+ cells in patients with myelodysplastic syndrome: correlation with apoptosis

  2003cited by this paper
• Mechanisms of Bcr-Abl-mediated NF-κB/Rel activation

  2003cited by this paper
• NF-κB transcription factor induces drug resistance through MDR1 expression in cancer cells

  2003cited by this paper
• Resveratrol blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells.

  2003cited by this paper
• Expression of TNF receptors and related signaling molecules in the bone marrow from patients with myelodysplastic syndromes.

  2003cited by this paper
• Detection by the fluorescence in situ hybridization technique of MYC translocations in paraffin‐embedded lymphoma biopsy samples

  2003cited by this paper
• Identification of NF-κB-regulated genes induced by TNFα utilizing expression profiling and RNA interference

  2003cited by this paper
• Identification of NF-kappa B-regulated genes induced by TNFalpha utilizing expression profiling and RNA interference.

  2003cited by this paper
• Curcumin (Diferuloylmethane) Inhibits Constitutive and IL-6-Inducible STAT3 Phosphorylation in Human Multiple Myeloma Cells 1

  2003cited by this paper
• Potentiation of tumour apoptosis by human growth hormone via glutathione production and decreased NF-κB activity

  2003influential reference
• A phase 2 study of bortezomib in relapsed, refractory myeloma.

  2003cited by this paper
• Effect of NF-κB/Rel inhibition on spontaneous vs chemotherapy-induced apoptosis in AML and normal cord blood CD34+ cells

  2003cited by this paper
• Expression and prognostic significance of Bcl‐2 family proteins in myelodysplastic syndromes

  2002cited by this paper
• Increased IkappaB kinase activity is associated with activated NF-kappaB in acute myeloid blasts.

  2002cited by this paper
• Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2.

  2002cited by this paper
• Increased IκB kinase activity is associated with activated NF-κB in acute myeloid blasts

  2002cited by this paper
• NF-κB in cancer: from innocent bystander to major culprit

  2002cited by this paper
• The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis.

  2002cited by this paper
• Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications.

  2002cited by this paper
• The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

  2002cited by this paper
• The function of multiple IκB : NF-κB complexes in the resistance of cancer cells to Taxol-induced apoptosis

  2002cited by this paper
• NF-kappaB in cancer: from innocent bystander to major culprit.

  2002cited by this paper
• Preferential induction of apoptosis for primary human leukemic stem cells

  2002cited by this paper
• Nuclear factor k B is activated in myelodysplastic bone marrow cells.

  2002influential reference
• Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades.

  2001cited by this paper
• The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells.

  2001cited by this paper
• Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signalling cascades

  2001cited by this paper
• Constitutive Nuclear Factor κB Activity Is Required for Survival of Activated B Cell–like Diffuse Large B Cell Lymphoma Cells

  2001cited by this paper
• Signaling pathways activated by daunorubicin.

  2001cited by this paper
• Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells.

  2001cited by this paper
• Inhibition of NF-kappa B activity by thalidomide through suppression of IkappaB kinase activity.

  2001cited by this paper
• Analysis of expression of nuclear factor kappa B (NF-kappa B) in multiple myeloma: downregulation of NF-kappa B induces apoptosis.

  2001cited by this paper
• Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel

  2001cited by this paper
• Analysis of expression of nuclear factor κB (NF‐κB) in multiple myeloma: downregulation of NF‐κB induces apoptosis

  2001cited by this paper
• Inhibition of NF-κB Activity by Thalidomide through Suppression of IκB Kinase Activity*

  2001cited by this paper
• Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia.

  2001cited by this paper
• Enhancement of cytosine arabinoside-induced apoptosis in human myeloblastic leukemia cells by NF-κB/Rel− specific decoy oligodeoxynucleotides

  2000cited by this paper
• NF-κB as a Central Mediator in the Induction of TGF-β in Monocytes from Patients with Idiopathic Myelofibrosis: An Inflammatory Response Beyond the Realm of Homeostasis1

  2000cited by this paper
• Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells.

  2000cited by this paper
• In vitro and in vivo production of vascular endothelial growth factor by chronic lymphocytic leukemia cells.

  2000cited by this paper
• Blockade of the Bcr-Abl Kinase Activity Induces Apoptosis of Chronic Myelogenous Leukemia Cells by Suppressing Signal Transducer and Activator of Transcription 5–Dependent Expression of Bcl-XL

  2000cited by this paper
• Modulation of NF-κB Activity and Apoptosis in Chronic Lymphocytic Leukemia B Cells1

  2000cited by this paper
• Clonal Deleterious Mutations in the Iκbα Gene in the Malignant Cells in Hodgkin's Lymphoma

  2000cited by this paper
• NF-kappa B as a central mediator in the induction of TGF-beta in monocytes from patients with idiopathic myelofibrosis: an inflammatory response beyond the realm of homeostasis.

  2000cited by this paper
• Cellular origin of human B-cell lymphomas.

  1999cited by this paper
• Phenylarsine oxide blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, and induces apoptosis of acute myelogenous leukemia cells.

  1999cited by this paper
• Persistent activation of NF-kappaB by the tax transforming protein of HTLV-1: hijacking cellular IkappaB kinases.

  1999cited by this paper
• Persistent activation of NF-κB by the Tax transforming protein of HTLV-1: hijacking cellular IκB kinases

  1999cited by this paper
• Quinine improves results of intensive chemotherapy (IC) in myelodysplastic syndromes (MDS) expressing P-glycoprotein (PGP). Updated results of a randomized study. Groupe Français des Myélodysplasies (GFM) and Groupe GOELAMS.

  1999cited by this paper

• Clathrin-associated SCYL2 contributes to the activation of PI3K/AKT signaling and tumorigenesis through PTEN phosphorylation in adult T-cell leukemia/lymphoma.

  2026cites this paper
• IL-1β Controls Proliferation, Apoptosis, and Necroptosis Through the PI3K/AKT/Src/NF-κB Pathway in Leukaemic Lymphoblasts

  2025cites this paper
• Amicis Omnia Sunt Communia: NF-κB Inhibition as an Alternative to Overcome Osteosarcoma Heterogeneity

  2024cites this paper
• Mycovirus-Containing Aspergillus flavus Alters Transcription Factors in Normal and Acute Lymphoblastic Leukemia Cells

  2024cites this paper
• Inflammation as a driver of hematological malignancies

  2024cites this paper
• Anti-Inflammatory and Cancer-Preventive Potential of Chamomile (Matricaria chamomilla L.): A Comprehensive In Silico and In Vitro Study

  2024cites this paper
• Jozimine A2, a Dimeric Naphthylisoquinoline (NIQ) Alkaloid, Shows In Vitro Cytotoxic Effects against Leukemia Cells through NF-κB Inhibition

  2024cites this paper
• Recent Advances towards the Understanding of Secondary Acute Myeloid Leukemia Progression

  2024cites this paper
• Endothelial Robo4 suppresses endothelial-to-mesenchymal transition induced by irradiation and improves hematopoietic reconstitution

  2024cites this paper
• Results from phase 1 of the MANIFEST clinical trial to evaluate the safety and tolerability of pelabresib in patients with myeloid malignancies

  2024cites this paper
• Predicting single cell genotypes from single cell expression profiles in AML using deep learning

  2023cites this paper
• PHF6 maintains acute myeloid leukemia via regulating NF-κB signaling pathway

  2023cites this paper
• NF-kB and the CLL microenvironment

  2023cites this paper
• Targeting metabolism: A potential strategy for hematological cancer therapy

  2022cites this paper
• The Anti-Leukemia Effect of Ascorbic Acid: From the Pro-Oxidant Potential to the Epigenetic Role in Acute Myeloid Leukemia

  2022cites this paper
• Pathways of Angiogenic and Inflammatory Cytokines in Multiple Myeloma: Role in Plasma Cell Clonal Expansion and Drug Resistance

  2022cites this paper
• The molecular biology and therapeutic potential of Nrf2 in leukemia

  2022cites this paper
• Hinokiflavone induces apoptosis, cell cycle arrest and autophagy in chronic myeloid leukemia cells through MAPK/NF-κB signaling pathway

  2022cites this paper
• The Ube2m-Rbx1 neddylation-Cullin-RING-Ligase proteins are essential for the maintenance of Regulatory T cell fitness

  2022cites this paper
• Bone Marrow Microenvironment as a Source of New Drug Targets for the Treatment of Acute Myeloid Leukaemia

  2022cites this paper
• A Novel Defined Pyroptosis-Related Gene Signature for the Prognosis of Acute Myeloid Leukemia

  2022cites this paper
• Complex genotype-phenotype relationships shape the response to treatment of down syndrome childhood acute lymphoblastic leukaemia

  2022cites this paper
• Molecular Action of Polyphenols in Leukaemia and Their Therapeutic Potential

  2021cites this paper
• Gene-editing, immunological and iPSCs based therapeutics for muscular dystrophy.

  2021cites this paper
• Proteasome 26S subunit, non-ATPases 1 (PSMD1) and 3 (PSMD3), play an oncogenic role in chronic myeloid leukemia by stabilizing nuclear factor-kappa B

  2021cites this paper
• Inflammatory Pathophysiology as a Contributor to Myeloproliferative Neoplasms

  2021cites this paper
• The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges

  2020cites this paper
• NT157 has antineoplastic effects and inhibits IRS1/2 and STAT3/5 in JAK2V617F-positive myeloproliferative neoplasm cells

  2020cites this paper
• Old Drugs, New Uses: Drug Repurposing in Hematological Malignancies.

  2020cites this paper
• MicroRNAs: pivotal regulators in acute myeloid leukemia

  2020cites this paper
• Anti-VEGF Drugs in the Treatment of Multiple Myeloma Patients

  2020cites this paper
• Vitamin E δ-tocotrienol inhibits TNF-α-stimulated NF-κB activation by up-regulation of anti-inflammatory A20 via modulation of sphingolipid including elevation of intracellular dihydroceramides.

  2019cites this paper
• Mechanisms of apoptosis modulation by curcumin: Implications for cancer therapy

  2019cites this paper
• NF‐κB targeting for overcoming tumor resistance and normal tissues toxicity

  2019cites this paper
• Epigenetic modifiers DNMT3A and BCOR are recurrently mutated in CYLD cutaneous syndrome

  2019cites this paper
• Antitumor Mechanism of the Essential Oils from Two Succulent Plants in Multidrug Resistance Leukemia Cell

  2019cites this paper
• Novel Targeted Nano-Parthenolide Molecule against NF-kB in Acute Myeloid Leukemia

  2019cites this paper
• Hydroxycoumarin OT-55 kills CML cells alone or in synergy with imatinib or Synribo: Involvement of ER stress and DAMP release.

  2018cites this paper
• The novel piperazine-containing compound LQFM018: Necroptosis cell death mechanisms, dopamine D4 receptor binding and toxicological assessment.

  2018cites this paper
• 1,3-Diphenylpropanes from Daphne giraldii induced apoptosis in hepatocellular carcinoma cells through nuclear factor kappa-B inhibition.

  2018cites this paper
• Study of Neuropilin-1/cd304 Expression in Leukemogenesis

  2018cites this paper
• Ablation of miR-146b in mice causes hematopoietic malignancy.

  2018cites this paper
• PRIMA-1 induces caspase-mediated apoptosis in acute promyelocytic leukemia NB4 cells by inhibition of nuclear factor-&kgr;B and downregulation of Bcl-2, XIAP, and c-Myc

  2017cites this paper
• Aurora A and NF-κB Survival Pathway Drive Chemoresistance in Acute Myeloid Leukemia via the TRAF-Interacting Protein TIFA.

  2017cites this paper
• Apoptosis Induced by the Curcumin Analogue EF-24 Is Neither Mediated by Oxidative Stress-Related Mechanisms nor Affected by Expression of Main Drug Transporters ABCB1 and ABCG2 in Human Leukemia Cells

  2017cites this paper
• Aberrant control of NF-κB in cancer permits transcriptional and phenotypic plasticity, to curtail dependence on host tissue: molecular mode

  2017cites this paper
• Lp16-PSP, a Member of YjgF/YER057c/UK114 Protein Family Induces Apoptosis and p21WAF1/CIP1 Mediated G1 Cell Cycle Arrest in Human Acute Promyelocytic Leukemia (APL) HL-60 Cells

  2017cites this paper
• Canonical NFκB signaling in myeloid cells is required for the glioblastoma growth

  2017cites this paper
• Total coumarins of Hedyotis diffusa induces apoptosis of myelodysplastic syndrome SKM-1 cells by activation of caspases and inhibition of PI3K/Akt pathway proteins.

  2017cites this paper
• Targeting Thioredoxin-1 by dimethyl fumarate induces ripoptosome-mediated cell death

  2017cites this paper
• Deregulated Levels of the NF-κB1, NF-κB2, and Rel Genes in Ukrainian Patients with Leukemia and Lymphoma in the Post-Chernobyl Period

  2016cites this paper
• Nucleophosmin Mutations Induce Chemosensitivity in THP-1 Leukemia Cells by Suppressing NF-κB Activity and Regulating Bax/Bcl-2 Expression

  2016cites this paper
• CXCR4 expression on pathogenic T cells facilitates their bone marrow infiltration in a mouse model of aplastic anemia.

  2015cites this paper
• Drug Resistance in Multiple Myeloma: How to Cross the

  2015cites this paper
• NF-κB and AKT signaling prevent DNA damage in transformed pre-B cells by suppressing RAG1/2 expression and activity.

  2015cites this paper
• Novel Quinone Methide Precursors: Enhanced Sensitivity and Selectivity towards Chronic Lymphocytic Leukemia (CLL) Cells

  2015cites this paper
• Cell line-specific oxidative stress in cellular toxicity: A toxicogenomics-based comparison between liver and colon cell models.

  2015cites this paper
• BIIB021, an Hsp90 inhibitor, effectively kills a myelodysplastic syndrome cell line via the activation of caspases and inhibition of PI3K/Akt and NF-κB pathway proteins

  2014cites this paper
• Regulation of p53 and Rb Links the Alternative NF-κB Pathway to EZH2 Expression and Cell Senescence

  2014cites this paper
• Microparticles induce multifactorial resistance through oncogenic pathways independently of cancer cell type

  2014cites this paper
• The role of inflammation in leukaemia.

  2014cites this paper
• Chemo-sensitizing effects of EP4 receptor-induced inactivation of nuclear factor-κB.

  2014cites this paper
• The TAK1-NF-κB axis as therapeutic target for AML.

  2014cites this paper
• The role of CDX2 in inflammatory bowel disease.

  2014cites this paper
• Cytotoxic effects of caffeic acid undecyl ester are involved in the inhibition of telomerase activity in NALM-6 human B-cell leukemia cells

  2013cites this paper
• Bortezomib sensitivity of acute myeloid leukemia CD34(+) cells can be enhanced by targeting the persisting activity of NF-κB and the accumulation of MCL-1.

  2013cites this paper
• Protein Glutathionylation in Cardiovascular Diseases

  2013cites this paper
• High Concentrations of L-Ascorbic Acid Specifically Inhibit the Growth of Human Leukemic Cells via Downregulation of HIF-1α Transcription

  2013cites this paper
• CCL5 as a potential immunotherapeutic target in triple-negative breast cancer

  2013cites this paper
• Inhibition of Nuclear Factor Kappa B activation in Early-Stage Chronic Lymphocytic Leukemia by Omega-3 Fatty Acids

  2013cites this paper
• Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms

  2013cites this paper
• Omega-3 Fatty Acids as Therapeutic Options for the Treatment of B-cell Chronic Lymphocytic Leukemia

  2013cites this paper
• Omega-3 Fatt y Acids as The rapeutic Options for the Treatment of B-cell Chronic Lymphocytic Leukemia

  2013cites this paper
• Function of MicroRNA-146a and NF-κB in Physiologic and Pathologic Hematopoiesis

  2013cites this paper
• Selective Cytotoxicity of Amidinopiperidine Based Compounds Towards Burkitt’s Lymphoma Cells Involves Proteasome Inhibition

  2012cites this paper
• Clinical and prognostic significance of miR-155 and miR-146a expression levels in formalin-fixed/paraffin-embedded tissue of patients with diffuse large B-cell lymphoma.

  2012cites this paper
• Budowa i funkcje jądrowego czynnika transkrypcyjnego NF kappa B (NF-κB) oraz jego znaczenie w przewlekłej białaczce limfocytowej

  2012cites this paper
• Role of VEGF/VEGFR in the pathogenesis of leukemias and as treatment targets (Review).

  2012cites this paper
• Src, Akt, NF-κB, BCL-2 and c-IAP1 may be involved in an anti-apoptotic effect in patients with BCR-ABL positive and BCR-ABL negative acute lymphoblastic leukemia.

  2012cites this paper
• LYG-202 Augments Tumor Necrosis Factor-α-Induced Apoptosis via Attenuating Casein Kinase 2-Dependent Nuclear Factor-κB Pathway in HepG2 Cells

  2012cites this paper
• Frequency of inherited variants in the MEFV gene in myelodysplastic syndrome and acute myeloid leukemia

  2012cites this paper
• H-ferritin overexpression promotes radiation-induced leukemia/lymphoma in mice.

  2012cites this paper
• Differentiation and Cell Survival of Myeloid Leukemia Cells

  2012cites this paper
• Imatinib treatment inhibit IL‐6, IL‐8, NF‐KB and AP‐1 production and modulate intracellular calcium in CML patients

  2012cites this paper
• High frequency of inherited variants in the MEFV gene in patients with hematologic neoplasms: a genetic susceptibility?

  2012cites this paper
• The Interface between BCR-ABL-Dependent and -Independent Resistance Signaling Pathways in Chronic Myeloid Leukemia

  2012cites this paper
• Para-NO-aspirin inhibits NF-κB and induces apoptosis in B-cell progenitor acute lymphoblastic leukemia.

  2012cites this paper
• attenuating CK2-dependent nuclear factor- B pathway in HepG2 cells

  2012cites this paper
• microRNA regulation of inflammatory responses.

  2012cites this paper
• S-Glutathionylation signaling in cell biology: progress and prospects.

  2012cites this paper
• Hyperforin Inhibits Akt1 Kinase Activity and Promotes Caspase-Mediated Apoptosis Involving Bad and Noxa Activation in Human Myeloid Tumor Cells

  2011cites this paper
• Bioimaging analysis of nuclear factor‐κB activity in Philadelphia chromosome‐positive acute lymphoblastic leukemia cells reveals its synergistic upregulation by tumor necrosis factor‐α‐stimulated changes to the microenvironment

  2011cites this paper
• MicroRNA-146a and hemopoietic disorders

  2011cites this paper
• MAP kinases in inflammatory bowel disease.

  2011cites this paper
• DETERMINACION DE LA RELACION ENTRE LA ACTIVACION DEL FACTOR DE TRANSCRIPCION NF-KB Y LA EXPRESION DE LAS PROTEINAS ANTIAPOPTOTICAS BCI2 Y CIAP EN LA LEUCEMIA LINFOBLASTICA AGUDA DE NOVO

  2011cites this paper
• High Frequency of Inherited Variants in the MEFV Gene in Acute Lymphocytic Leukemia

  2011cites this paper
• The role of CDX2 in intestinal homeostasis and inflammation.

  2011cites this paper
• MicroRNA function in myeloid biology.

  2011cites this paper
• NF-κB Suppresses ROS Levels in BCR-ABL+ Cells to Prevent Activation of JNK and Cell Death

  2011influential citation
• Human lysosomal α-D-mannosidase regulation in promyelocytic leukaemia cells.

  2011cites this paper